دورية أكاديمية
Disease modification in osteoarthritis; pathways to drug approval
| العنوان: | Disease modification in osteoarthritis; pathways to drug approval |
|---|---|
| المؤلفون: | Katz, Jeffrey N., Neogi, Tuhina, Callahan, Leigh F., Block, Joel A., Conaghan, Philip G., Simon, Lee S., Kraus, Virginia Byers, Hochberg, Marc C. |
| المساهمون: | Osteoarthritis Research Society International, NIH, Samumed, Flexion Therapeutics, EMD-Merck Serono, Pfizer, NIDR, Novartis, TissueGene, Daiichi-Sankyo, Agios, Omeros, GlaxoSmithKline, AbbVBie, BMS, Lilly, Elsevier, Walters Kluwer |
| المصدر: | Osteoarthritis and Cartilage Open ; volume 2, issue 2, page 100059 ; ISSN 2665-9131 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2020 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.ocarto.2020.100059 |
| الإتاحة: | https://doi.org/10.1016/j.ocarto.2020.100059Test https://api.elsevier.com/content/article/PII:S2665913120300480?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S2665913120300480?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: | edsbas.D1A8BEF5 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.ocarto.2020.100059 |
|---|